530 related articles for article (PubMed ID: 33303638)
41. Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study.
Kwok R; Choi KC; Wong GL; Zhang Y; Chan HL; Luk AO; Shu SS; Chan AW; Yeung MW; Chan JC; Kong AP; Wong VW
Gut; 2016 Aug; 65(8):1359-68. PubMed ID: 25873639
[TBL] [Abstract][Full Text] [Related]
42. Potential impact of screening for fatty liver disease by transient elastography with liver stiffness and controlled attenuation parameter measurements: a pilot study.
Peiseler M; Creutzfeldt A; Cassens I; Glaubke C; Kroll C; Lohse AW; Weiler-Normann C
Z Gastroenterol; 2017 Aug; 55(8):754-760. PubMed ID: 28655068
[No Abstract] [Full Text] [Related]
43. Prevalence and severity of nonalcoholic fatty liver disease by transient elastography: Genetic and metabolic risk factors in a general population.
Petta S; Di Marco V; Pipitone RM; Grimaudo S; Buscemi C; Craxì A; Buscemi S
Liver Int; 2018 Nov; 38(11):2060-2068. PubMed ID: 29577560
[TBL] [Abstract][Full Text] [Related]
44. Association between hypertension and the prevalence of liver steatosis and fibrosis.
Fu H; Yu H; Zhao Y; Chen J; Liu Z
BMC Endocr Disord; 2023 Apr; 23(1):85. PubMed ID: 37081417
[TBL] [Abstract][Full Text] [Related]
45. Prepandemic Prevalence Estimates of Fatty Liver Disease and Fibrosis Defined by Liver Elastography in the United States.
Unalp-Arida A; Ruhl CE
Dig Dis Sci; 2023 Apr; 68(4):1237-1252. PubMed ID: 36173583
[TBL] [Abstract][Full Text] [Related]
46. Hepatic Fibrosis Associates With Multiple Cardiometabolic Disease Risk Factors: The Framingham Heart Study.
Long MT; Zhang X; Xu H; Liu CT; Corey KE; Chung RT; Loomba R; Benjamin EJ
Hepatology; 2021 Feb; 73(2):548-559. PubMed ID: 33125745
[TBL] [Abstract][Full Text] [Related]
47. Modest alcohol intake not associated with significant hepatic steatosis or more severe liver disease among patients with diabetes mellitus.
Tan EZ; Lai LL; Vethakkan SR; Nik Mustapha NR; Mahadeva S; Chan WK
J Gastroenterol Hepatol; 2021 Mar; 36(3):751-757. PubMed ID: 32583444
[TBL] [Abstract][Full Text] [Related]
48. FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study.
Newsome PN; Sasso M; Deeks JJ; Paredes A; Boursier J; Chan WK; Yilmaz Y; Czernichow S; Zheng MH; Wong VW; Allison M; Tsochatzis E; Anstee QM; Sheridan DA; Eddowes PJ; Guha IN; Cobbold JF; Paradis V; Bedossa P; Miette V; Fournier-Poizat C; Sandrin L; Harrison SA
Lancet Gastroenterol Hepatol; 2020 Apr; 5(4):362-373. PubMed ID: 32027858
[TBL] [Abstract][Full Text] [Related]
49. Assessment of Steatosis and Fibrosis in Liver Transplant Recipients Using Controlled Attenuation Parameter and Liver Stiffness Measurements.
Mikolasevic I; Hauser G; Mijic M; Domislovic V; Radic-Kristo D; Krznaric Z; Razov-Radas M; Pavic T; Matasin M; Filipec Kanizaj T
Can J Gastroenterol Hepatol; 2021; 2021():6657047. PubMed ID: 33628759
[TBL] [Abstract][Full Text] [Related]
50. Prevalence and risk factors of nonalcoholic steatohepatitis with significant fibrosis in people with HIV.
Michel M; Labenz C; Wahl A; Anders M; Armandi A; Huber Y; Galle PR; Sprinzl M; Schattenberg JM
AIDS; 2022 Oct; 36(12):1665-1674. PubMed ID: 35849074
[TBL] [Abstract][Full Text] [Related]
51. Transient Elastography and Serum-Based Tests for Diagnosis of Fatty Liver and Advanced Fibrosis in a Community Cohort: A Cross-Sectional Analysis.
Le MH; Henry L; Cheung R; Nguyen MH
Dig Dis; 2023; 41(5):767-779. PubMed ID: 35973400
[TBL] [Abstract][Full Text] [Related]
52. Marijuana use is inversely associated with liver steatosis detected by transient elastography in the general United States population in NHANES 2017-2018: A cross-sectional study.
Du R; Tang XY; Yang C; Gao WH; Gao SJ; Xiang HJ; Yang L
PLoS One; 2023; 18(5):e0284859. PubMed ID: 37200309
[TBL] [Abstract][Full Text] [Related]
53. Liver steatosis and nonalcoholic fatty liver disease with fibrosis are predictors of frailty in people living with HIV.
Milic J; Menozzi V; Schepis F; Malagoli A; Besutti G; Franconi I; Raimondi A; Carli F; Mussini C; Sebastiani G; Guaraldi G
AIDS; 2020 Nov; 34(13):1915-1921. PubMed ID: 33009010
[TBL] [Abstract][Full Text] [Related]
54. Transient Elastography-Assessed Hepatic Steatosis and Fibrosis Are Associated With Body Composition in the United States.
Unalp-Arida A; Ruhl CE
Clin Gastroenterol Hepatol; 2022 Apr; 20(4):e808-e830. PubMed ID: 33549867
[TBL] [Abstract][Full Text] [Related]
55. Visceral Adipose Tissue and Non-alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes.
Nobarani S; Alaei-Shahmiri F; Aghili R; Malek M; Poustchi H; Lahouti M; Khamseh ME
Dig Dis Sci; 2022 Apr; 67(4):1389-1398. PubMed ID: 33788095
[TBL] [Abstract][Full Text] [Related]
56. Accuracy of FibroTouch in assessing liver steatosis and fibrosis in patients with metabolic-associated fatty liver disease combined with type 2 diabetes mellitus.
Yu H; Liu H; Zhang J; Jia G; Yang L; Zhang Q; Li G; Liu F; Di F; Wang F
Ann Palliat Med; 2021 Sep; 10(9):9702-9714. PubMed ID: 34628896
[TBL] [Abstract][Full Text] [Related]
57. Feasibility of Fibroscan in Assessment of Hepatic Steatosis and Fibrosis in Obese Patients: Report From a General Internal Medicine Clinic.
Avcu A; Kaya E; Yilmaz Y
Turk J Gastroenterol; 2021 May; 32(5):466-472. PubMed ID: 34231477
[TBL] [Abstract][Full Text] [Related]
58. Lack of awareness of liver organ damage in patients with type 2 diabetes.
Ciardullo S; Monti T; Perseghin G
Acta Diabetol; 2021 May; 58(5):651-655. PubMed ID: 33496855
[TBL] [Abstract][Full Text] [Related]
59. Transient elastography as a screening tool for liver fibrosis in a large hemodialysis population.
Cheng BC; Yen YH; Chen JF; Wu CK; Chang KC; Tseng PL; Tsai MC; Lin MT; Lin JT; Chen JB; Hu TH
Sci Rep; 2017 Apr; 7():46458. PubMed ID: 28422172
[TBL] [Abstract][Full Text] [Related]
60. Prevalence of non-alcoholic fatty liver disease (NAFLD) in a cohort of patients with type 2 diabetes: the PHIGNA-DM2 study.
Martínez-Ortega AJ; Piñar Gutiérrez A; Lara-Romero C; Remón Ruiz PJ; Ampuero-Herrojo J; de Lara-Rodríguez I; Romero-Gómez M; García Luna PP; Soto-Moreno A
Nutr Hosp; 2022 Oct; 39(5):1012-1018. PubMed ID: 36134588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
